The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-11 of 11 articles
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I,
Verheye S,
Dubois C,
Dens J,
Farah B,
Carrié D,
Walsh S,
Oldroyd K,
Varenne O,
El-Jack S,
Moreno R,
Christen T,
Allocco D
April 20, 2018 | 10.4244/EIJ-D-17-00529
Belgium: coronary and structural heart interventions from 2010 to 2015
Desmet W,
Aminian A,
Kefer J,
Dens J,
Bosmans J,
Claeys M,
Dubois C,
Gach O,
Janssens L,
Schröder E,
Vermeersch P,
Carlier M,
Benit E,
Hanet C
May 15, 2017 | 10.4244/EIJ-D-16-00825
COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial
Dubois C,
Bennett J,
Dens J,
De Cock D,
Desmet W,
Belmans A,
Ughi G,
Sinnaeve P,
Vrolix M,
D’hooge J,
Adriaenssens T
April 20, 2016 | 10.4244/EIJY15M05_02
Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial
Adriaenssens T,
Dens J,
Ughi G,
Bennett J,
Dubois C,
Sinnaeve P,
Wiyono S,
Coosemans M,
Belmans A,
D’hooge J,
Vrolix M,
Desmet W
August 19, 2014 | 10.4244/EIJV10I4A77
Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial
Legrand V,
Cuisset T,
Chenu P,
Vrolix M,
Martinez C,
Dens J,
Gach O,
Boland J,
Claeys M,
Magne J,
Barbato E,
Wijns W
June 20, 2014 | 10.4244/EIJV10I2A34
Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions
Abizaid A,
Ormiston J,
Fajadet J,
Mauri L,
Schofer J,
Verheye S,
Dens J,
Thuesen L,
Macours N,
Qureshi A,
Spaulding C
October 25, 2013 | 10.4244/EIJV9I6A116
Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study
Buysschaert I,
Dubois C,
Dens J,
Ormiston J,
Worthley SG,
McClean D,
Ottervanger J,
Meredith I,
Uren N,
Wijns W,
Whitbourn R,
Mehran R,
Lansky A,
Bichalska M,
Meis S,
Verheye S
September 27, 2013 | 10.4244/EIJV9I5A93
A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry
Agostoni P,
Foley DP,
Lesiak M,
Belkacemi A,
Dens J,
Kumsars I,
Scott B,
Oemrawsingh P,
Dubois C,
Garcia E,
Lefèvre T,
Stella P
March 21, 2012 | 10.4244/EIJV7I11A204
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023